Effect of Sourdough Breads Consumption on Postprandial Responses, Satiety and Food Intake at Subsequent Meal
SUPPRESS
1 other identifier
interventional
43
1 country
1
Brief Summary
During this project the effect of different types of sourdough breads consumption on satiety, energy intake at subsequent meal and postprandial metabolic responses, will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2021
CompletedFirst Posted
Study publicly available on registry
March 9, 2021
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 5, 2024
CompletedMay 14, 2024
May 1, 2024
2.7 years
February 24, 2021
May 13, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
Appetite measurements
Appetite in response to test meal, will be measured using 100 millimeter (mm) Visual Analogue Scales (VAS) before eating (i.e. 0 minute) and at respective time points after completion of test meal (I.e. 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240 minutes).
During test day 1 (up to 4 hours)
Appetite measurements
Appetite in response to test meal, will be measured using 100 millimeter (mm) Visual Analogue Scales (VAS) before eating (i.e. 0 minute) and at respective time points after completion of test meal (I.e. 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240 minutes).
During test day 2 (up to 4 hours)
Appetite measurements
Appetite in response to test meal, will be measured using 100 millimeter (mm) Visual Analogue Scales (VAS) before eating (i.e. 0 minute) and at respective time points after completion of test meal (I.e. 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240 minutes).
During test day 3 (up to 4 hours)
Food intake at subsequent meal
Weighted amounts of ad-libitum food offered minus the weighted leftovers
During test day 1 (240 minutes after ingestion of breakfast)
Food intake at subsequent meal
Weighted amounts of ad-libitum food offered minus the weighted leftovers
During test day 2 (240 minutes after ingestion of breakfast)
Food intake at subsequent meal
Weighted amounts of ad-libitum food offered minus the weighted leftovers
During test day 3 (240 minutes after ingestion of breakfast)
Secondary Outcomes (25)
Oral processing behaviour
During test day 1 (up to 15 minutes)
Oral processing behaviour
During test day 2 (up to 15 minutes)
Oral processing behaviour
During test day 3 (up to 15 minutes)
Blood lipids
During test day 1
Blood lipids
During test day 2
- +20 more secondary outcomes
Study Arms (3)
Wholemeal bread
ACTIVE COMPARATORTreatment with wholemeal bread
Sourdough bread
ACTIVE COMPARATORTreatment with sourdough bread
Bread with sourdough
ACTIVE COMPARATORTreatment with bread with sourdough
Interventions
180g wholemeal bread/day + fixed portion at test day
180g sourdough bread/day + fixed portion at test day
180g bread with sourdough/day + fixed portion at test day
Eligibility Criteria
You may qualify if:
- Female and male participants
- age range 18 - 50
- BMI range 18.5 - 25.0 kg/m2 at screening visit
- Regular eating pattern (3 meals per day on at least 5 days per week)
- Willingness to consume bread (180 g) on a daily base
- Stable body weight for the last 6 months
You may not qualify if:
- Currently smoking (has smoked in the last 28 days) or willingness to smoke during the study period
- Pregnancy, lactation or wish to become pregnant during the study period
- Family history of diabetes
- Previous or current gastrointestinal or endocrine disorders
- Previous or current substance/alcohol dependence or abuse (\> 2 units per day/14 units per week)
- Intake of prescription medication
- Coeliac disease or gluten sensitivity
- Use of pre- or probiotics within one month preceding the study
- Use of antibiotics within 3 months preceding the study
- Excessive concern about eating habits or body weight as evidenced from scores \< 18 on the restraint and disinhibition subscales of the Three-Factor Eating Questionnaire (Stunkard \& Messick, 1985)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
Study Sites (1)
KU Leuven/ UZ Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristin Verbeke, Prof.
KU Leuven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 24, 2021
First Posted
March 9, 2021
Study Start
June 1, 2021
Primary Completion
February 5, 2024
Study Completion
February 5, 2024
Last Updated
May 14, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share